Tag Archives: Schering Plough

Pharma: Trust Deficit or the Biggest Image Problem ever faced?

  It was  Saturday afternoon; April 4th, to be precise. 7-time Tour de France winner and full-time cancer fighter: Lance Armstrong was in his born-state Texas, riding to give a speech in the PhRMA meeting in San Antonio. From his … Continue reading

Posted in Alta Dirección, Mercadotecnia, Opinión, Salud, Ventas | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 3 Comments

2009 Pharma Mergers. A comprehensive analysis facing the future.

The last two months have been full of surprises in the Pharmaceutical arena. January was not even ending, when Pfizer was announcing its intentions of taking over Wyeth. Just some days after a month later and after a more-than-nervous weekend, … Continue reading

Posted in Alta Dirección, Mercadotecnia, Opinión, Salud, Ventas | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 3 Comments

De Dinosaurios, Sexo y Fusiones.

El analista farmacéutico español Miguel A. Tovar comenta en Blogaceutics, su blog especializado en la Industria Farmacéutica sobre la fusión entre Merck y Schering-Plough. Documentado como siempre, Miguel se muestra escéptico ante el éxito que pueda tener a futuro esta operación. Comparando esta … Continue reading

Posted in Alta Dirección, Blogs, Opinión, Salud, Web | Tagged , , , , , , , , , | Leave a comment

Merck will buy Schering-Plough for $41.1 Bn USD

By Xavier Tello Merck (or Merck Sharp & Dohme) will buy Schering- Plough for $41.1Bn USD in cash and stock, according to Bloomberg and Reuters. Despite the speculations during the weekend that J&J could be a stronger bidder, and Merck’s … Continue reading

Posted in Alta Dirección, Mercadotecnia, Planeac. Estratégica, Ventas | Tagged , , , , , , , , , , , , | 1 Comment

Is Schering-Plough the New target for an acquisition?

By Xavier Tello Schering-Plough is one of the most successful Pharma companies coming from late 20th century.   With a good an solid tradition of R&D, Schering (as is known in the USA) could be considered one of the “Big … Continue reading

Posted in Alta Dirección, Mercadotecnia, Planeac. Estratégica, Ventas | Tagged , , , , , , , , , , , , , , , , , , , , , , | 1 Comment